Last updated 2026-07-23
- Raised $56k grant, Jun 2019
Total raised
$56K
Last: Grant 2019-07
Stage
Pre-Funding
Founded
2011
Headcount
6
HQ
Jerusalem, Israel
Sector
Health Tech & Life Sciences
About
LipoMedix is a development-stage privately held company focused on developing an innovative, safe, and effective cancer therapy based on liposome delivery. The company's lead product, Promitil® (PL-MLP), is a pegylated liposomal mitomycin-C prodrug designed for selective delivery of the therapeutic agent to cancer-affected tissues, aiming to overcome the toxicity associated with conventional mitomycin-C. LipoMedix is advancing the pharmaceutical and clinical development of this patented new chemical entity. LipoMedix is majority owned by Rafael Holdings, Inc..
Funding history · 1 round · $56K total
2019-06
Grant
$56K
Q&A
- What is LipoMedix's primary focus?
- LipoMedix is a development-stage company focused on innovative, safe, and effective cancer therapy based on liposome delivery.
- What is LipoMedix's lead product?
- LipoMedix's lead product is Promitil, which has demonstrated antitumor effects in tumor models.
- When was LipoMedix founded?
- LipoMedix was founded in June 2011.
- What is LipoMedix's current product stage?
- LipoMedix's product is in the clinical trial stage.
- Has LipoMedix received any funding?
- Yes, LipoMedix received a Grant round in July 2019 from the European Commission.
- Who are the founders of LipoMedix?
- The founders of LipoMedix are Al Gabizon, who serves as Founder & President, and Rami Kremien, a Co-founder.
- What is LipoMedix's primary sector classification?
- LipoMedix's primary sector is Health Tech & Life Sciences.
Team · 2
Alberto Gabizon
Founder · Founder & Chief Scientific Advisor
Rami Kremien
Founder · Co-founder
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug Delivery
Technologies
Biologicals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
1 PatentsVerified
Tags
canceroncologybiopharmaceuticaldrug-deliverytargeted-therapychemotherapytherapeuticspharmaceuticalspharma-companies
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | lipomedix.com |
|---|
Identifiers & details
| Legal name | Lipomedix Pharmaceuticals Ltd. |
|---|---|
| Founded | 2011-6 |
| Employees (exact) | 6 |
Acquisitions & public offerings
Acquired by 2018-06
Radar intelligence
Patents
| EPO | 4 |
|---|
Publications (Crossref)
| Works | 4 |
|---|
Web history (Wayback)
| Domain | lipomedix.com |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 514549997 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2011-01-06 |
| Purpose | לעסוק בסוגי עיסוק שפורטו בתקנון |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2024 |
| Active charges / liens | 0 |
| Registry events | 0 |
| Registered address | הגן הטכנולוגי 0 ירושלים |